Clinical Outsourcing Development DNA Research 
pharmaphorum
JULY 5, 2021
billion to claim ownership of the contract research organisation. The CRO “successfully adapted the business to work in the midst of a global pandemic, and supported the development of therapies to combat the COVID-19 pandemic itself,” said Pamplona’s managing partner John Halsted.
Drug Discovery World
SEPTEMBER 29, 2022
For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. Three common questions regarding the challenges when considering outsourcing partners for drug discovery.
Expert insights. Personalized for you.
64 
Let's personalize your content